• Cell Bio Human Tech will terminate its 1 billion won buyback trust contract on Oct. 21, 2026, following completion of purchases.
• The trust acquired 167,284 common shares, bringing total treasury holdings to 1,204,005 shares, or 12.82% of outstanding stock.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cell Bio Human Tech Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261021000068), on October 21, 2026, and is solely responsible for the information contained therein.